Insulin and dexamethasone regulate insulin receptors, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in Fao hepatoma cells - PubMed (original) (raw)
Insulin and dexamethasone regulate insulin receptors, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in Fao hepatoma cells
M J Saad et al. Endocrinology. 1995 Apr.
Abstract
Insulin rapidly stimulates tyrosine kinase activity of its receptor, resulting in phosphorylation of the cytosolic substrate, insulin receptor substrate-1 (IRS-1), which, in turn, associates with phosphatidylinositol 3-kinase (PI 3-kinase), thus activating the enzyme. In the present study we have examined these three early postreceptor components of the insulin action pathway in rat hepatoma (Fao) cells and have determined the effects of two hormones that can induce insulin resistance, dexamethasone and insulin. Dexamethasone (1 microM) induced a time- and dose-dependent increase in insulin receptor levels in Fao cells, reaching 135 +/- 3% of basal levels after 24 h (P < 0.05). There was a simultaneous increase in IRS-1 protein to 255 +/- 66% of the control value (P < 0.05) and a parallel increase in IRS-1 phosphorylation. Insulin stimulation of IRS-1-associated PI 3-kinase was also increased by 70% in cells treated with dexamethasone despite only a minimal increase in PI 3-kinase protein, as determined by immunoblotting. Prolonged insulin treatment induced a time- and dose-dependent decrease in insulin receptor and IRS-1 protein levels, reaching nadirs of 40 +/- 4% (P < 0.01) and 15 +/- 6% (P < 0.005) of control levels, respectively, after 24 h with 100 nM insulin. There was also a decrease in the phosphorylation of insulin receptors and IRS-1, a marked decrease in the association between IRS-1 and PI 3-kinase, and an 82% decrease in insulin-stimulated PI 3-kinase activity without a significant change in PI 3-kinase protein levels. When cells were exposed to both insulin and dexamethasone, the effect of insulin to reduce insulin receptor and IRS-1 levels and insulin-stimulated IRS-1 phosphorylation dominated. These data suggest that regulation of the insulin receptor, IRS-1, and PI 3-kinase contributes significantly to the insulin resistance induced by chronic hyperinsulinemia, but that glucocorticoid-induced insulin resistance is located beyond these early steps in insulin action.
Similar articles
- Regulation of insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and dexamethasone.
Saad MJ, Folli F, Araki E, Hashimoto N, Csermely P, Kahn CR. Saad MJ, et al. Mol Endocrinol. 1994 May;8(5):545-57. doi: 10.1210/mend.8.5.7520127. Mol Endocrinol. 1994. PMID: 7520127 - Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats.
Saad MJ, Folli F, Kahn JA, Kahn CR. Saad MJ, et al. J Clin Invest. 1993 Oct;92(4):2065-72. doi: 10.1172/JCI116803. J Clin Invest. 1993. PMID: 7691892 Free PMC article. - Effect of aging on insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of rats.
Carvalho CR, Brenelli SL, Silva AC, Nunes AL, Velloso LA, Saad MJ. Carvalho CR, et al. Endocrinology. 1996 Jan;137(1):151-9. doi: 10.1210/endo.137.1.8536607. Endocrinology. 1996. PMID: 8536607 - Molecular mechanisms of insulin resistance.
Saad MJ. Saad MJ. Braz J Med Biol Res. 1994 Apr;27(4):941-57. Braz J Med Biol Res. 1994. PMID: 8087096 Review. - Insulin receptor/IRS-1/PI 3-kinase signaling system in corticosteroid-induced insulin resistance.
Folli F, Saad MJ, Kahn CR. Folli F, et al. Acta Diabetol. 1996 Sep;33(3):185-92. doi: 10.1007/BF02048541. Acta Diabetol. 1996. PMID: 8904923 Review. No abstract available.
Cited by
- Synergistic effects of glucose tolerance and BMI on cardiovascular events and all-cause mortality in a healthy population: CA.ME.LI.A study 7 years follow-up.
Bignotto M, Bianco E, Centofanti L, Russo A, Dei Cas M, Zermiani P, Morano C, Samartin F, Bertolini E, Bifari F, Berra C, Zuin M, Paroni R, Battezzati PM, Folli F. Bignotto M, et al. Am J Physiol Endocrinol Metab. 2024 Oct 1;327(4):E498-E511. doi: 10.1152/ajpendo.00181.2024. Epub 2024 Aug 28. Am J Physiol Endocrinol Metab. 2024. PMID: 39196799 Free PMC article. - A genome-wide siRNA screen to identify modulators of insulin sensitivity and gluconeogenesis.
Yang R, Lacson RG, Castriota G, Zhang XD, Liu Y, Zhao W, Einstein M, Camargo LM, Qureshi S, Wong KK, Zhang BB, Ferrer M, Berger JP. Yang R, et al. PLoS One. 2012;7(5):e36384. doi: 10.1371/journal.pone.0036384. Epub 2012 May 9. PLoS One. 2012. PMID: 22590537 Free PMC article. - Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.
Holland WL, Summers SA. Holland WL, et al. Endocr Rev. 2008 Jun;29(4):381-402. doi: 10.1210/er.2007-0025. Epub 2008 May 1. Endocr Rev. 2008. PMID: 18451260 Free PMC article. Review. - Role of metabolically active hormones in the insulin resistance associated with short-term glucocorticoid treatment.
Patel JV, Cummings DE, Girod JP, Mascarenhas AV, Hughes EA, Gupta M, Lip GY, Reddy S, Brotman DJ. Patel JV, et al. J Negat Results Biomed. 2006 Sep 11;5:14. doi: 10.1186/1477-5751-5-14. J Negat Results Biomed. 2006. PMID: 16965635 Free PMC article. Clinical Trial. - Distinct regulation of IRS proteins in adipose tissue from obese aged and dexamethasone-treated rats.
Caperuto LC, Anhê GF, Amanso AM, Ribeiro LM, Medina MC, Souza LC, Carvalho OM, Bordin S, Saad MJ, Carvalho CR. Caperuto LC, et al. Endocrine. 2006 Jun;29(3):391-8. doi: 10.1385/ENDO:29:3:391. Endocrine. 2006. PMID: 16943575
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous